The US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

A lot happens in Boston every day. To help you keep up, WBUR, Boston's NPR News station, pulled these stories together just for you.

The Department of Disease Control warns of rising Covid-19 cases—nearly 50,000 last week—and expects the outbreak to continue for 2–3 months. Flu cases are steady with 300,000+ infections and 33 ...

Top officials at the FDA outlined a new framework for approving Covid-19 vaccines, saying that the US would make the boosters available for Americans over the age of 65 and for adults and children ...

Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the ...

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

World Health Organization member countries on Tuesday approved an agreement to better prevent, prepare for and respond to ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday.

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...